-+ 0.00%
-+ 0.00%
-+ 0.00%

Cresco Labs closes US$50 million acquisition of nine Pennsylvania dispensaries from PharmaCann Penn

PUBT·09/02/2026 10:30:45
Listen to the news
Cresco Labs closes US$50 million acquisition of nine Pennsylvania dispensaries from PharmaCann Penn
  • Cresco Labs closed the acquisition of PharmaCann Penn for USD 50 million, adding nine operating medical marijuana dispensaries in Pennsylvania.
  • Deal terms include cash and a seller note, structured on a cash-free, debt-free basis with a normalized working-capital target.
  • Transaction lifts Cresco to the top retail position in Pennsylvania’s medical cannabis market, which generated more than USD 1.1 billion in annual sales last year.
  • Management expects the acquisition to be immediately accretive to revenue, margins, and cash flow.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cresco Labs Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260902305608) on September 02, 2026, and is solely responsible for the information contained therein.